The Gross Margin of Arcutis Biotherapeutics Inc (ARQT) is 90.24%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2025-12-31 | 90.24% |
| 2024-12-31 | 90.27% |
| 2023-12-31 | 91.63% |
| 2022-12-31 | 79.67% |